Ilika full year results in an extraordinary year

stereax

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, announced its full-year results for the year ended 30 April 2020.

Operational highlights:

·    Increased commercial demand for evaluation samples of Stereax® miniature solid-state batteries triggering investment in large volume manufacturing capacity

·    Specified and ordered key equipment to support 70x increase in Stereax manufacturing capacity

·    Implemented portfolio of Medtech and IIoT Stereax development and field trial programmes with five commercial partners, including:

o  High-value asset tagging with Lightricity

o  Wind turbine monitoring with Titan Wind

o  Rail network infrastructure monitoring with Network Rail

o  Environmental sensing with ePeas

o  Miniature medical implants with multiple med-tech partners

·    Innovated Stereax performance by implementing photolithographic techniques compatible with low-cost industrial manufacturing processes and achieved 10x increase in energy density for ultra-thin cells for medical implants

·    Grew Stereax patent portfolio with a further eight granted patents in five jurisdictions

·    Secured a Goliath large format cell development programme with Jaguar Land Rover, bringing the total grant funding support from the Faraday Battery Challenge to ÂŁ5.1m over three projects

·    Designed, outfitted and opened a new facility for the pre-pilot development of Goliath cells within nine months

·    Received the Green Economy Classification from the London Stock Exchange for contributing to a more sustainable economy

·    Maintained safe operations complying with COVID-19 Government guidelines without a material impact on the business to date

Financial highlights:

·    Turnover ÂŁ2.8m (2019: ÂŁ2.6m)

·    Adjusted EBITDA Loss for the year ÂŁ2.1m (2019: Adjusted EBITDA loss ÂŁ2.2m)

·    Loss per share 2.95p (2019: 2.42p)

·    Cash, cash equivalents and bank deposits of ÂŁ14.8m (2019: ÂŁ4.0m)

·    Raised net proceeds of c.ÂŁ14.2m via an over-subscribed placing in March 2020

Outlook

With the funding in place for the next stage of development and a roadmap to grow its portfolio of products, the Company remains strongly positioned to take advantage of growing demand for solid state battery solutions. The Company remains well placed to fulfil the strategic objectives laid out at March’s oversubscribed fundraise with the proposed transfer of Stereax into a third-party fabrication facility. The shift to the make and sell model and the ability to intensify commercial scale up of Stereax added to further progress with Goliath are expected to deliver significant revenue growth opportunities.

Commenting on the results Ilika plc Chairman, Keith Jackson, said: “This has been an extraordinary year in more than one way, and I feel enormously proud of the way the team has delivered and taken advantage of challenges. The installation of the Goliath large format battery labs was done at great pace, with very little waste and was accompanied with an overhead saving on premises to give us the facilities we require to progress Goliath. The COVID-19 lockdown did temporarily limit access to our Stereax pilot line and restrict some of our working but the team quickly set up new work processes and used the limited fallow time to investigate and improve the way they work, so on the safe return to the labs they could be even more effective.

“At a technical level the team has made great progress on the batteries, particularly with the energy density of Stereax where every increase in density increases the addressable market. Not only have improvements been made, there are options and opportunities to increase the density further and thereby the addressable markets. Finally, the team has worked hard to paint a clear picture of what we do and where we are going as a business to our investors, culminating in the Company’s successful placing in March 2020, which underpins the next phase of our growth strategy. The team is now focussed on the scale up of new Stereax capacity and further advancing the technology in Goliath. This will not be without its challenges but with our committed and agile team we are confident of a successful outcome.”

An investor presentation will be held later today, 9 July 2020, at 4.30pm and will be hosted through the digital platform, Investor Meet Company. Investors can sign up to Investor Meet Company for free and add Ilika plc via the following link:https://www.investormeetcompany.com/ilika-plc/register-investor or for more information please contact Walbrook PR at [email protected].

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search